MedPath

SEPTODONT, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

17

FDA:13
CANADA:2

Drug Approvals

Zorcaine

Approval Date
Mar 6, 2024
FDA

Septocaine and Epinephrine

Approval Date
Mar 4, 2024
FDA

Carbocaine

Approval Date
Feb 21, 2024
FDA

Scandonest 3% Plain

Approval Date
Feb 21, 2024
FDA

Vivacaine

Approval Date
Feb 16, 2024
FDA

Lidocaine

Approval Date
Feb 8, 2024
FDA

Lignospan Standard

Approval Date
Feb 8, 2024
FDA

Lignospan Forte

Approval Date
Feb 5, 2024
FDA

Lidocaine

Approval Date
Jul 7, 2023
FDA

DycloPro

Approval Date
Jan 6, 2022
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.